HBV Infection Screening Recommendations Revisited
the MPR take:
Current evidence does not support screening for hepatitis B virus (HBV) infection in asymptomatic adolescents and adults, confirming the U.S. Preventive Services Task Force (USPSTF)’s 2004 decision. This review, published in the Annals of Internal Medicine, found no direct evidence on the effects of HBV screening compared to no screening on clinical outcomes; randomized trials of antiviral therapy in reducing the risk for clinical outcomes associated with HBV infection had no statistically significant results. While antiviral therapy had beneficial effects on intermediate histologic, serologic, and virologic outcomes, findings on education and other interventions to reduce transmission or improve health outcomes were lacking.
READ FULL ARTICLE From Annals